Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Hypothyroidism

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Hypothyroidism in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henley, WN1
Vladic, F1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Hypothyroidism

ArticleYear
Hypothyroid-induced changes in autonomic control have a central serotonergic component.
    The American journal of physiology, 1997, Volume: 272, Issue:2 Pt 2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Atropine; Autonomic Nervous System; B

1997